10x Genomics is trading 4.34% down at $55.47 as growth stocks retreat alongside a weaker Nasdaq and S&P 500.

  • Rising Treasury yields and higher oil prices are pressuring rate-sensitive technology and biotechnology shares after the U.S.-Iran ceasefire expired.
  • The 30-year Treasury yield reached its highest level since 2007.
  • No clear company-specific announcement was found for August 18, 2026; the August 17 insider-sale report does not directly explain today’s move.